| Transfer of reboxetine into breastmilk, its plasma concentrations and lack of adverse effects in the breastfed infant. | |
| | |
MedLine Citation:
|
PMID: 16699799 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To investigate the transfer of reboxetine into milk, the absolute and relative infant doses via milk and to assess plasma concentrations and adverse unwanted effects in the breastfed infant. METHODS: Multiple samples of blood and milk were obtained over a dose interval at steady-state from four women who were taking reboxetine for postnatal depression. Drug concentrations in plasma and milk were measured by high performance liquid chromatography and milk/plasma ratio (M/P), absolute infant dose and relative infant dose were estimated by standard methods. Their four, breastfed, infants were also examined clinically, and a blood sample was taken for drug analysis. RESULTS: The median (range) dose taken by the women was 6 (4-10) mg/day. There was no significant difference in reboxetine concentration between paired fore-and hind-milk samples. The mean (95% CI) M/P was 0.06 (0.03, 0.09). Absolute infant dose was 1.7 (0.7, 2.4) microg/kg/day for reboxetine while the relative infant dose was 2.0% (1.3, 2.7%). Three of the infants met normal developmental milestones and no adverse effects were seen in any infant. The fourth infant had developmental problems that were not associated with the maternal reboxetine therapy. The concentrations of reboxetine in plasma from the four infants were <4 microg/l, 2.6 microg/l, 2.3 microg/l and 5 microg/l, respectively. CONCLUSION: The study suggests that reboxetine use by lactating women is safe for the breastfed infant. Nevertheless, our study had only four mother/baby pairs, and each decision to breastfeed should always be made on the basis of an individual risk/benefit analysis. |
| | |
Authors:
|
L Peter Hackett; Kenneth F Ilett; Jonathan Rampono; Judith H Kristensen; Rolland Kohan |
Related Documents
:
|
8265319 - Secretory anti-giardia lamblia antibodies in human milk: protective effect against diar... 21700899 - Hypothermia is correlated with seizure absence in perinatal stroke. 8789559 - Identification of the complement regulatory protein cd59 in human colostrum and milk. 17619799 - Organochlorine pesticide residues in human milk of mothers living in northern tunisia. 3668039 - Relation of registration with yield and termination of first lactation in dairy goats. 8250499 - Role of plasma phosphate measurements in detecting rickets of prematurity and in monito... 11911759 - Relationship of prenatal diagnosis and pregnancy termination to overall infant mortalit... 2603709 - Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase ... 14988469 - Nutrition influences bone development from infancy through toddler years. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't Date: 2006-05-13 |
Journal Detail:
|
Title: European journal of clinical pharmacology Volume: 62 ISSN: 0031-6970 ISO Abbreviation: Eur. J. Clin. Pharmacol. Publication Date: 2006 Aug |
Date Detail:
|
Created Date: 2006-07-26 Completed Date: 2007-01-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1256165 Medline TA: Eur J Clin Pharmacol Country: Germany |
Other Details:
|
Languages: eng Pagination: 633-8 Citation Subset: IM |
Affiliation:
|
Clinical Pharmacology & Toxicology Laboratory, PathWest Laboratory Medicine, Nedlands, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antidepressive Agents / adverse effects*, blood, therapeutic use Area Under Curve Chromatography, High Pressure Liquid Depression, Postpartum / drug therapy Female Humans Infant, Newborn Male Milk, Human / chemistry* Morpholines / adverse effects*, blood, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents; 0/Morpholines; 98769-81-4/reboxetine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rupture of rudimentary uterine horn pregnancy at 37 weeks gestation with fetal survival.
Next Document: Primary care physicians' behaviors towards risk of iatrogenesis in elderly patients.